2022

Zexuan Yu#, Mengtong Wu#, Yingshuang Huang, Yishu Wang, Yijun Chen, Qiulin Long, Ziming Lin, Lingjing Xue, Caoyun Ju*, Can Zhang*. Single-component lipid nanoparticles for engineering SOCS1 gene-silenced dendritic cells to boost tumor immunotherapy. Biomaterials Science. 2022. DOI: 10.1039/d2bm01549h. (IF: 7.590)

2022 Single-component lipid nanoparticles for engineering SOCS1 gene-silenced dendritic cells to boost tumor immunotherapy.pdf




Yijun Chen#, Kaiming Li#, Mengying Jiao#, Yingshuang Huang, Zihao Zhang, Lingjing Xue, Caoyun Ju*, Can Zhang*. Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy. Acta Pharmaceutica Sinica B. 2022. DOI:10.1016/j.apsb.2022.08.012. (IF: 14.903)

2022 Reprogrammed siTNFα neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy..pdf




Hai Ye, Tian Lv, Tao Min, Di Mao, Xingran Chen, Boxiang Ding, Can Zhang*. HR1405-01, a Safe intravenous NSAID with superior anti-inflammatory and analgesic activities in preclinical trials. European Journal of Medicinal Chemistr. 2022, 235: 114258.

2022 HR1405-01, a Safe intravenous NSAID with superior antiinflammatory and analgesic activities in preclinical trials.pdf




XY Li, COT Qizi, AM Khamis, C Zhang*, ZG Su*. Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells. Pharmaceutical Research. 2022, 39: 1065-1083. (IF: 4.58)

2022 Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells.pdf







HY Wu#, WS Li#, MX Hao, YJ Wang, LJ Xue, CT Ju*, C Zhang*. An EPR-Independent extravasation Strategy: Deformable leukocytes as vehicles for improved solid tumor therapy. Advanced Drug Delivery Reviews. 2022, 187: 114380. (IF: 17.873）

2022 An EPR independent extravasation Strategy  Deformable leukocytes as vehicles for improved solid tumor therapy.pdf







JJ Du#, C Wang#, YJ Chen, LY Zhong, XWT Liu, LJ Xue, Y Zhang, YY Li, XY Li, CM Tang, ZG Su*, C Zhang*. Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis. Journal of Controlled Release. 2022, 343, 457-468. (IF: 11.467)

2022 Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis.pdf







Y Zhang#, C Wang#, WS Li, W Tian, CM Tang, LJ Xue, ZM Lin, GL Liu, DF Liu, Y Zhou, QQ Wang, X Wang, Lutz Birnbaumer, Y Yang, XJ Li*, CY Ju*, C Zhang*. Neutrophil cyto-pharmaceuticals suppressing tumor metastasis via inhibiting hypoxia-inducible factor-1α in circulating breast cancer cells. Advanced Healthcare Materials. 2022, 11(3): e2101761. (IF: 11.092)

2022 Neutrophil cyto-pharmaceuticals suppressing tumor metastasis via inhibiting hypoxia-inducible factor-1α in circulating breast cancer cells.pdf




Zhuqing Sun, Jingtong Chen, Guangcun Chen, Can Zhang*, Chunyan Li*. Recent advances of engineered and artificial drug delivery system towards solid tumor based on immune cells. Biomedical Materials. 2022, 17(2): 022002.

2022 Recent advances of engineered and artificial drug delivery system towards solid tumor based on immune cells.pdf